By Blake Brittain WASHINGTON -A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic ...
Hosted on MSN49m
First paediatric patient recruited for Dimerix’s ACTION3 kidney disease drug trialThe first paediatric patient for Dimerix’s ACTION3 phase III clinical trial into a rare kidney disease has been recruited at ...
Amid concerns the additive causes cancer, the FDA is implementing a ban on a popular food dye used in candy and cakes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback